Arizona State Retirement System Mirati Therapeutics, Inc. Transaction History

Arizona State Retirement System

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$41.99 - $62.38 $114,464 - $170,047	-2,726 Reduced 18.81%	11,764 $691,000
Q3 2023 Nov 06, 2023	BUY	$27.8 - $45.35 $85,290 - $139,133	3,068 Added 26.86%	14,490 $631,000
Q2 2023 Aug 01, 2023	SELL	$36.13 - $49.49 $9,321 - $12,768	-258 Reduced 2.21%	11,422 $412,000
Q1 2023 Apr 27, 2023	BUY	$36.54 - $54.26 $25,431 - $37,764	696 Added 6.34%	11,680 $434,000
Q4 2022 Feb 07, 2023	BUY	$41.27 - $98.62 $17,374 - $41,519	421 Added 3.99%	10,984 $497,000
Q3 2022 Nov 07, 2022	BUY	$59.5 - $86.7 $2,201 - $3,207	37 Added 0.35%	10,563 $738,000
Q2 2022 Jul 28, 2022	BUY	$39.16 - $88.71 $3,054 - $6,919	78 Added 0.75%	10,526 $707,000
Q1 2022 May 04, 2022	BUY	$75.82 - $150.97 $54,742 - $109,000	722 Added 7.42%	10,448 $859,000
Q4 2021 Feb 04, 2022	SELL	$132.01 - $190.29 $10,824 - $15,603	-82 Reduced 0.84%	9,726 $1.43 Million
Q3 2021 Nov 12, 2021	BUY	$132.13 - $177.45 $22,858 - $30,698	173 Added 1.8%	9,808 $1.74 Million
Q2 2021 Aug 02, 2021	SELL	$144.0 - $179.73 $87,984 - $109,815	-611 Reduced 5.96%	9,635 $1.56 Million
Q1 2021 May 06, 2021	BUY	$158.92 - $221.61 $294,002 - $409,978	1,850 Added 22.03%	10,246 $1.76 Million
Q4 2020 Jan 28, 2021	SELL	$162.05 - $240.27 $26,414 - $39,164	-163 Reduced 1.9%	8,396 $1.84 Million
Q3 2020 Nov 05, 2020	BUY	$113.26 - $167.27 $246,906 - $364,648	2,180 Added 34.17%	8,559 $1.42 Million
Q2 2020 Aug 04, 2020	BUY	$72.01 - $120.39 $25,995 - $43,460	361 Added 6.0%	6,379 $728,000
Q1 2020 May 05, 2020	BUY	$69.78 - $116.21 $419,936 - $699,351	6,018 New	6,018 $463,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.